Evaluation of the Effect of Rehabilitation Sport After Total Hip Arthroplasty (THA)

August 16, 2018 updated by: Technische Universität Dresden

Randomized, Clinical Survey for Evaluating the Effect of Rehabilitation Sport on Patients Who Underwent Total Hip Arthroplasty (THA)

160 patients who received a total hip arthroplasty (THA) were included and randomized to receive specific rehabilitation sport (RS) or not (control) in addition to a conventional rehabilitation program. Upon completion of the rehabilitation phase 6 weeks, 6 months and 12 months after surgery sports medical measurements have been performed. Strength abilities of the hip muscles were tested with isokinetic dynamometry, postural control with a force measuring platform and endurance via lactate measurements.

Study Overview

Detailed Description

In Germany, rehabilitation sport (RS) is a reimbursed postoperative measure in order to support socio-professional reintegration and self-help.

160 patients who received a primary total hip arthroplasty (THA) were included and randomized to receive specific RS or not (control) in addition to a conventional rehabilitation program. Upon completion of the rehabilitation phase 6 weeks, 6 months and 12 months after surgery sports medical measurements have been performed. Strength abilities of the hip muscles were tested with isokinetic dynamometry, postural control with a force measuring platform and endurance via lactate measurements. The goal of the study was to prospectively randomized evaluate the effect of RS on hip-related muscular strength, endurance and postural stability on patients who underwent THA.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • non-complicated THA
  • written informed consent

Exclusion Criteria:

  • complicated THA
  • partial weight-bearing after surgery
  • cardial comorbidities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: with rehabilitation sport
rehabilitation sport over 52 weeks after THA, start 6 weeks postoperatively
rehabilitation Sport over 52 weeks after THA, start 6 weeks postoperatively
No Intervention: without rehabilitation sport
no further rehabilitation program after THA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hip-related muscular strength
Time Frame: change from baseline (6 weeks) at 6 months after THA
hip-related muscular strength measured with isokinetic dynamometry
change from baseline (6 weeks) at 6 months after THA

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip pain - WOMAC
Time Frame: change from 6 months to 12 months after THA
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore (worst=0, best=100)
change from 6 months to 12 months after THA
Physical function hip - WOMAC
Time Frame: change from 6 months to 12 months after THA
WOMAC Total Score (worst=0, best=100)
change from 6 months to 12 months after THA
Physical function hip - HHS
Time Frame: change from 6 months to 12 months after THA
Harris-Hip-Score (worst=0, best=100)
change from 6 months to 12 months after THA
Physical Activity
Time Frame: change from 6 months to 12 months after THA
University of California, Los Angeles (UCLA) Activity Scale (worst=1, best=10)
change from 6 months to 12 months after THA
health related Quality of life
Time Frame: change from 6 months to 12 months after THA
EuroQol in 5 dimensions (EQ-5D) Index (worst=0, best=1), EQ-VAS (worst=0, best=100)
change from 6 months to 12 months after THA
Hip pain
Time Frame: change from 6 months to 12 months after THA
Visual Analogue Scale (worst=0, best=10)
change from 6 months to 12 months after THA
cardiovascular endurance
Time Frame: change from baseline (6 weeks) at 6 months after THA
cardiovascular endurance via lactate measurements
change from baseline (6 weeks) at 6 months after THA
cardiovascular endurance
Time Frame: change from baseline (6 weeks) at 12 months after THA
cardiovascular endurance via lactate measurements
change from baseline (6 weeks) at 12 months after THA
postural control
Time Frame: change from baseline (6 weeks) at 6 months after THA
postural control with a force measuring platform
change from baseline (6 weeks) at 6 months after THA
postural control
Time Frame: change from baseline (6 weeks) at 12 months after THA
postural control with a force measuring platform
change from baseline (6 weeks) at 12 months after THA
hip-related muscular strength
Time Frame: change from baseline (6 weeks) at 12 months after THA
hip-related muscular strength measured with isokinetic dynamometry
change from baseline (6 weeks) at 12 months after THA

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2015

Primary Completion (Actual)

July 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

June 4, 2018

First Submitted That Met QC Criteria

July 11, 2018

First Posted (Actual)

July 12, 2018

Study Record Updates

Last Update Posted (Actual)

August 17, 2018

Last Update Submitted That Met QC Criteria

August 16, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • rehasport after THA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

no plan to share IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Hip

Clinical Trials on rehabilitation sport

Subscribe